CellSeed Inc 7776
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- JPY 211.00
- Day Range
- JPY 201.00–210.00
- 52-Week Range
- JPY 201.00–587.00
- Bid/Ask
- JPY 202.00 / JPY 203.00
- Market Cap
- JPY 6.43 Bil
- Volume/Avg
- 239,100 / 570,845
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 31.92
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
CellSeed Inc is a Japanese biotechnology company. The company is involved in the research, development, marketing, and sale of cell-sheet regenerative medicines, such as epithelial cell sheet for corneal and esophageal regeneration; regenerated cardiac patch to treat heart diseases; cell sheet for periodontal tissue regeneration; and regenerated cartilage sheet for the treatment of osteoarthritis.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 35
- Website
- http://www.cellseed.com
Comparables
Valuation
|
Metric
|
7776
|
4599
|
4563
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 84.77 | — |
Price/Book Value | 3.07 | 2.75 | 0.39 |
Price/Sales | 31.92 | 11.83 | 63.11 |
Price/Cash Flow | — | 37.09 | — |
Price/Earnings
7776
4599
4563
Financial Strength
|
Metric
|
7776
|
4599
|
4563
|
|---|---|---|---|
Quick Ratio | 18.43 | 73.99 | 1.68 |
Current Ratio | 19.03 | 79.18 | 2.38 |
Interest Coverage | −748.70 | 9,063.95 | — |
Quick Ratio
7776
4599
4563
Profitability
|
Metric
|
7776
|
4599
|
4563
|
|---|---|---|---|
Return on Assets (Normalized) | −33.11% | 1.48% | −16.00% |
Return on Equity (Normalized) | −39.88% | 1.52% | −19.90% |
Return on Invested Capital (Normalized) | −36.65% | 1.52% | −19.26% |
Return on Assets
7776
4599
4563
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Pgycgpnbz | Vjfdr | $553.3 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Zslpmdxy | Ydtwzm | $101.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Yyvnxrt | Ftncw | $98.1 Bil | |
MRNA
| Moderna Inc | Kjlxtkzj | Dsmtv | $39.7 Bil | |
ARGX
| argenx SE ADR | Qwmftsncq | Ktdy | $21.5 Bil | |
BNTX
| BioNTech SE ADR | Cwqnlyd | Jnb | $20.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Bjrwgzvv | Hcqckd | $18.3 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Wcrrnvq | Tyhhxh | $17.1 Bil | |
RPRX
| Royalty Pharma PLC Class A | Nxlvmmvr | Ygsgxlg | $12.5 Bil | |
INCY
| Incyte Corp | Jskwchk | Rxwtvys | $11.8 Bil |